<DOC>
	<DOCNO>NCT02423980</DOCNO>
	<brief_summary>This open-label , exploratory pilot study patient T1D . The study involve two daytime clinical research center visit 7-14 day apart . Subjects receive single injection G-Pen™ ( glucagon injection ) visit .</brief_summary>
	<brief_title>G-Pen™ Hypoglycemia Rescue T1D</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Type 1 diabetes mellitus least 24 month Pregnant Lactating HbA1c &gt; 10.5 % screening Use &gt; 2.0 U/kg total insulin dose per day Inadequate bilateral venous access arm Renal insufficiency Congestive heart failure , NYHA class II , III IV Active malignancy within 5 year screen Major surgical operation within 30 day prior screen Seizure bleed disorder Glycogen storage disease Active substance alchohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>